Dual-Function Mammography, Prone Stereotactic Biopsy System Cleared by FDA

March 13, 2012 – Fischer Medical Technologies LLC (Fisher Medical), announces from the National Interdisciplinary Breast Center Conference that it has been named exclusive U.S. distributor of GIOTTO’s Full Field Digital Mammography (FFDM) systems.

After receiving 510(k) clearance by the FDA in November 2011 for the GIOTTO FFDM system, I.M.S. Srl (Internazionale Medico Scientifica) of Bologna Italy and Fischer Medical of Broomfield, Colo. signed a multiyear distribution agreement.  The newly-formed Fischer-GIOTTO division is headed by Bob Rusk, who formerly managed GIOTTO-USA.

The unique design of the GIOTTO system makes it possible to dedicate a single room for both upright mammography, as well as prone stereotactic biopsy.  The innovative tilting gantry ensures optimal positioning so that more breast tissue is included in the imaging field, increasing the ability to detect small cancers on the chest wall.  It also enables the mammogram procedure to be done “face to face;” a benefit to radiologists, technologists and patients alike.  The ring design of the GIOTTO system allows easy positioning of disabled wheelchair patients – the only known mammography system with this capability.

Morgan W. Nields, chairman and CEO of Fischer Medical said, “We are delighted with this agreement since the GIOTTO FFDM system has been installed in over 500 sites around the world and has demonstrated a proven track record of superb image quality and reliability.”

Vice President of International Sales at IMS in Bologna, Achille Alabanse said, “We have been gaining market share throughout the world and are very pleased to join forces with Fischer Medical. This agreement leverages Fischer’s deep knowledge and installed base of prone biopsy systems in the United States.”

For more information: www.giottousa.com


Related Content

News | Breast Imaging

April 2, 2024 — iCAD, Inc., a global leader in clinically proven AI-powered cancer detection solutions, announced ...

Time April 02, 2024
arrow
News | Breast Imaging

March 20, 2024 — Interval breast cancer is one that appears between two reviews of a screening program. That is, it is ...

Time March 20, 2024
arrow
News | Breast Imaging

March 15, 2024 — Screening-detected radial scars without atypia at core-needle biopsy (CNB) have a low upstaging rate to ...

Time March 15, 2024
arrow
News | Breast Imaging

March 6, 2024 — There is a pressing need to explore and understand which social determinants of health (SDOH) and health ...

Time March 06, 2024
arrow
News | Breast Imaging

February 20, 2024 — Annual breast cancer screening beginning at age 40 and continuing to at least age 79 results in the ...

Time February 20, 2024
arrow
News | Breast Imaging

February 9, 2024 — An innovative breast imaging technique provides high sensitivity for detecting cancer while ...

Time February 09, 2024
arrow
News | Breast Density

December 22, 2023 — Volpara Health Technologies Ltd., a global leader in software for the early detection and prevention ...

Time December 22, 2023
arrow
News | Breast Imaging

December 11, 2023 — A new deep learning challenge has been launched by the UEF Cancer AI research team, led by senior ...

Time December 11, 2023
arrow
News | RSNA

November 30, 2023 — Breast cancer mortality is significantly reduced when women regularly attend screening mammograms ...

Time November 30, 2023
arrow
News | Breast Imaging

November 29, 2023 — A deep learning artificial intelligence (AI) model that was developed using only mammogram image ...

Time November 29, 2023
arrow
Subscribe Now